07/05/2026
๐ ๐ฃ๐ฎ๐ฟ๐ฎ๐ฑ๐ถ๐ด๐บ ๐ฆ๐ต๐ถ๐ณ๐ ๐ถ๐ป ๐๐ผ๐ ๐๐ฎ๐ฐ๐ธ ๐ฃ๐ฎ๐ถ๐ป ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐: ๐ช๐ต๐ ๐ ๐ผ๐๐ฒ๐บ๐ฒ๐ป๐ ๐๐ฒ๐ฎ๐๐ ๐ฃ๐ถ๐น๐น๐ ๐ฎ๐ป๐ฑ ๐ฆ๐๐ฟ๐ด๐ฒ๐ฟ๐
โฌ Low back pain (LBP) has been the leading cause of global disability since 1990, yet our approach to treating it is often outdated, ineffective, and unnecessarily invasive.
โฌ A landmark 2026 review by Saragiotto and colleagues synthesized the highest-quality LBP research published between 2020 and 2025, breaking down contemporary LBP management into five key themes.
โฌ The overarching message is clear: LBP care is most effective when it is active, person-centered, and psychologically informed, while medications and surgeries carry high risks with little to no meaningful benefit.
๐ฆ ๐ฃ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ถ๐ผ๐ป: ๐ฆ๐ถ๐บ๐ฝ๐น๐ฒ, ๐ฆ๐ฐ๐ฎ๐น๐ฎ๐ฏ๐น๐ฒ, ๐ฎ๐ป๐ฑ ๐๐ฐ๐๐ถ๐๐ฒ
โฌ The evidence is consistent: exercise-based programs, especially when combined with education, can reduce the likelihood of a new LBP episode by 25% to 45%.
โฌ We don't need complex, expensive regimens to see results.
โฌ For example, a recent trial showed that an individualized walking program combined with brief education reduced the risk of an LBP recurrence by 20% and reduced LBP recurrences that required healthcare seeking by a staggering 43%.
โฌ When prevention efforts are focused on simple, scalable physical activity approaches, patients build resilience and reduce the long-term impact of pain.
๐ง ๐ก๐ผ๐ป-๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ฎ๐ฟ๐ฒ: ๐ ๐ถ๐ป๐ฑ ๐ฎ๐ป๐ฑ ๐๐ผ๐ฑ๐ ๐๐ผ๐ป๐ป๐ฒ๐ฐ๐๐ฒ๐ฑ
โฌ Non-pharmacological care should be the first line of defense, but not all therapies are created equal.
โฌ Exercise is Key, But Type Doesn't Matter: There is no single "magic" exercise for chronic LBP.
โฌ Whether it's Pilates, walking, or functional restoration, the best exercise is the one the patient enjoys and will do consistently.
โฌ Motivation and adherence are far more important than the specific biomechanics of the movement.
โฌ Psychologically Informed Care: The greatest gains in managing persistent LBP come from approaches that blend physical movement with psychological support.
โฌ Cognitive Functional Therapy (CFT), which builds movement confidence and addresses unhelpful beliefs, has been shown to produce large, sustained improvements in pain and disability for up to 3 years, saving over AU$5,000 per person in healthcare and societal costs.
โฌ Adjuncts, Not Fixes: Manual therapy and acupuncture can provide small, short-term relief, but they should only be used as add-ons to active rehabilitation, not as standalone "cures".
๐ ๐ง๐ต๐ฒ ๐๐ผ๐๐ป๐ณ๐ฎ๐น๐น ๐ผ๐ณ ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐
โฌ For decades, pills were the default answer to a bad back.
โฌ The latest evidence strongly contradicts this approach, showing that medicines offer minimal benefits and pose meaningful risks.
โฌ Paracetamol: High-certainty evidence shows paracetamol is no more effective than a placebo for acute LBP, and long-term use for chronic pain risks gastrointestinal bleeding and elevated blood pressure.
โฌ NSAIDs (e.g., Ibuprofen): These provide very little pain relief and increase the risk of gastrointestinal and cardiovascular harms.
โฌ Opioids: Opioids provide no benefit for acute LBP and very uncertain benefit for chronic LBP.
โฌ Shockingly, even short-term use of controlled-release opioids for acute pain can double a patient's risk of opioid misuse a year later.
โฌ Other Drugs: Muscle relaxants, gabapentinoids, and glucocorticoids show little to no meaningful benefit and are not routinely recommended.
โ ๏ธ ๐๐๐ผ๐ถ๐ฑ๐ถ๐ป๐ด ๐๐ป๐๐ฎ๐๐ถ๐๐ฒ ๐ฎ๐ป๐ฑ ๐ฆ๐๐ฟ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ป๐๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐ผ๐ป๐
โฌ The 2026 review paints a stark picture of invasive treatments.
โฌ Lumbar fusion, spinal injections, radiofrequency denervation, and spinal cord stimulators offer little to no long-term benefit for most chronic LBP patients.
โฌ Worse, these procedures expose patients to high costs and substantial complications like infections or revision surgeries.
โฌ Unless a patient has a highly specific conditionโlike clear nerve root compression or serious underlying pathologyโinvasive interventions should be avoided.
๐ ๐๐ฒ๐ฎ๐น๐๐ต ๐๐พ๐๐ถ๐๐ ๐ฎ๐ป๐ฑ ๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ฎ๐น ๐ฃ๐ผ๐ฝ๐๐น๐ฎ๐๐ถ๐ผ๐ป๐
โฌ Clinical trials often ignore the populations most impacted by LBP, leading to care that doesn't fit their unique needs.
โฌ Older Adults: Despite bearing the highest LBP burden, older adults are often excluded from research and are at a higher risk of receiving unnecessary imaging, opioids, and surgery.
โฌ Care must be tailored to their functional capacity, prioritizing group exercise and acupuncture over medications.
โฌ Children and Adolescents: LBP in youth is a strong predictor of chronic pain in adulthood.
โฌ The focus must be on reassurance, staying active in school and social lives, and supporting psychological well-being.
โฌ Indigenous and Underserved Communities: These populations experience disproportionately high rates of LBP but face immense structural barriers to receiving guideline-concordant care.
โฌ Addressing this requires moving beyond a purely biomedical framework and actively dismantling structural racism, implementing cultural humility training, and investing in community-led, equity-oriented care models.
โ
๐ง๐ต๐ฒ ๐๐ผ๐๐๐ผ๐บ ๐๐ถ๐ป๐ฒ
โฌ The evidence is unequivocal: we must shift away from low-value care like opioids and invasive procedures.
โฌ By prioritizing patient education, personalized exercise, psychologically informed therapies, and culturally safe care models, we can reduce the global burden of low back pain and improve lives across all communities.